Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2014
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary) ; Cisplatin; Etoposide
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2012 Planned End Date changed from 1 May 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 11 Nov 2011 Planned End Date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.